Yoshinobu Ichimura

Title: Innovations of Yoshinobu Ichimura in Tumor Diagnosis

Introduction

Yoshinobu Ichimura is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of medical science, particularly in the diagnosis and treatment of tumors. With a total of 2 patents, his work focuses on developing innovative reagents and methods that enhance the detection and treatment of cancer.

Latest Patents

Ichimura's latest patents include a reagent for diagnosing tumors, a pharmaceutical composition, and a screening method. These inventions provide antibodies that are useful for diagnosing and treating tumors. Specifically, his work involves an anti-phosphorylated p62 antibody that recognizes the phosphorylation of serine at position 351 of an amino acid sequence. This innovation allows for the diagnosis and treatment of tumors by identifying specific phosphorylated proteins. Furthermore, an antitumor agent can be discovered by screening for substances that inhibit phosphorylation or dephosphorylate the phosphorylated serine.

Career Highlights

Yoshinobu Ichimura is affiliated with the Tokyo Metropolitan Institute of Medical Science, where he conducts his research and development. His work has been instrumental in advancing the understanding of tumor biology and improving diagnostic techniques.

Collaborations

Ichimura collaborates with Masaaki Komatsu, a fellow researcher, to further enhance the impact of their innovations in the medical field.

Conclusion

Yoshinobu Ichimura's contributions to tumor diagnosis and treatment exemplify the importance of innovation in medical science. His patents reflect a commitment to improving healthcare outcomes through advanced research and collaboration.